Summary by Moomoo AI
Tri-Clover Biopharmaceuticals Co., Ltd. (Tri-Clover Bio-B) submitted the latest monthly report on securities changes to The Hong Kong Exchanges and Clearing Limited on September 3, 2024, reporting the shareholding changes as of August 31, 2024. The report shows that the company's statutory/registered share capital and issued shares (excluding treasury shares) remained unchanged during the reporting period, at 2,000,000,000 ordinary shares with a par value of $0.0001 per share. The total amount of statutory/registered share capital is $200,000, and the total number of issued shares is 1,297,048,929 shares. In addition, within the company's share option scheme, 4,000 share options from the pre-IPO stock option plan and 3,195,992 share options from the post-IPO stock option plan became invalid during the month, without any new shares being issued due to the exercise of options. The company confirms that all securities issuance or sale/transfers of treasury shares have been authorized by the board of directors and comply with relevant regulations.
